Analyst stock forecast
Ironwood Pharmaceuticals Forecast: $6.10 Analyst Target
IRWD has a $6.10 target, Buy rating and 4 analysts. As of 2026-08-19.
Direct answer
Ironwood Pharmaceuticals's average price target is $6.10.
The target implies +39.9% from the recorded current price, and the consensus rating is Buy.
The low target implies -15.1%, the high target implies +129.4%, and the range spans 144.5% of the current price.
Forecast evidence checked August 19, 2026.
Get free Ironwood Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.36
- Average price target
- $6.10
- High price target
- $10.00
- Low price target
- $3.70
- Low target gap
- -15.1%
- Target upside
- +39.9%
- High target gap
- +129.4%
- Target range width
- 144.5%
- Consensus rating
- Buy
- Analysts
- 4
- Evidence date
- August 19, 2026
- Valid through
- August 26, 2026
Explore related company data
Read the frequently asked questions.
What is Ironwood Pharmaceuticals's average price target?
Ironwood Pharmaceuticals's verified average price target is $6.10. The target range is $3.70 to $10.00.
How far are Ironwood Pharmaceuticals's low and high targets from the recorded price?
The low target implies -15.1%, while the high target implies +129.4%.
How many analysts are included in Ironwood Pharmaceuticals's consensus?
The verified consensus includes 4 analysts.
How is Ironwood Pharmaceuticals's target upside or downside calculated?
The average target of $6.10 is divided by the recorded price of $4.36, then one is subtracted to produce +39.9%. This does not guarantee a future return.
When was Ironwood Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-08-19. The dataset is valid through 2026-08-26.